Am J Transplant, Volume 20, Suppl 3 Archives - Page 135 of 223 - ATC Abstracts

2020 American Transplant Congress
Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients in the Current Era of Immunosuppression
M. Zachariah¹, I. Mallawaarachchi², N. Meeks³, D. Wright¹, R. Minawala¹, V. Liu¹, J. Rolls⁴, S. Hussein⁴, C. Jarrin⁵
¹Wayne State University, Detroit, MI, ²Division of Biostatistics, University of Virginia, Charlottsville, VA, ³Wayne State University School of Medicine, Detroit, MI, ⁴Surgery, Detroit Medical Center, Detroit, MI, ⁵Infectious Disease, Wayne State University, Detroit, MI
*Purpose: It is now common practice in the transplant community to select induction therapy on the basis of perceived immunological risk for acute rejection which…
2020 American Transplant Congress
Safety of A2 Incompatible Kidney Transplantation in Donors with Acute Kidney Injury
Y. Al Azzi, L. Liriano-Ward, G. Nair, M. Ajaimy, J. Graham, C. Pynadath, P. Nandigam, A. Colovai, A. Campbell, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin
Abdominal Transplant, Montefiore Medical Center, New York, NY
*Purpose: Kidneys with donor acute kidney injury (AKI) are frequently discarded. We aimed to study the outcomes of A2 incompatible kidney transplantation from donors with…
2020 American Transplant Congress
Calcium Oxalate Deposition in Kidney Allografts: Clinical Chracteristics and Outcome
S. Sritharan¹, J. Kamal², S. A. Husain¹, I. Batal¹, J. Chang¹
¹Columbia University Irving Medical Center, New York, NY, ²University of Virginia, Charlottesville, VA
*Purpose: To better understand its clinical significance and prognostic value, we investigated the clinical characteristics and outcomes of patients with calcium oxalate deposition in kidney…
2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Living Donor Kidney Transplantation
S. Getsin, P. Chiang, S. Yu, K. Jackson, D. Segev, A. Massie
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: ABO type B and O recipients have increased difficulty identifying a compatible donor for living-donor kidney transplantation (LDKT), and are harder to match in…
2020 American Transplant Congress
ESRD Risk Prediction for Black vs. White Related Living Kidney Donors
J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, L. Cartwright¹, D. Stewart¹
¹Research, UNOS, Richmond, VA, ²Chief Medical Officer, UNOS, Richmond, VA
*Purpose: We studied 25-year risk of post-donation ESRD in black (n=10,214) and white (n=45,700) first-degree related living kidney donors (RLKDs) who donated in the US…
2020 American Transplant Congress
Donor-Specific Antibody Test as a Screening Tool for Stable Long-Term Kidney Transplant Recipients
M. Mohamed¹, L. Hidalgo², S. Parajuli¹, N. Garg¹, F. Aziz¹, K. Swanson¹, E. Jochaim¹, D. Mandelbrot¹, A. Djamali¹, B. Astor¹
¹Department of Nephrology, Madison, WI, ²Department of Surgery, Madison, WI
*Purpose: Donor-specific antibody (DSA) is an established biomarker predicting antibody mediated rejection (AMR), but at substantial cost. The utility of DSA test as a screening…
2020 American Transplant Congress
What is the Significance of Denovo Donor Specific Antibodies in Recipients of Simultaneous Liver-Kidney Transplants?
S. Parajuli, F. Aziz, J. Blazel, B. Muth, N. Garg, M. Mohamed, J. Rice, J. Mezrich, L. Hidalgo, D. Mandelbrot, G. Im, B. Lee
University of Wisconsin, Madison, WI
*Purpose: There is limited information about the utility of donor-specific HLA antibody (DSA) testing and the role of protocol kidney biopsy for de-novo donor-specific antibodies…
2020 American Transplant Congress
Increased Level of Serum Cholesterol and Apoptosis Together Induces the Development of Liver Fibrosis and Early Allograft Loss
B. H. Ozdemir¹, G. Ozgun¹, E. H. Ayvazoglu Soy², N. Haberal¹, M. Haberal²
¹Pathology, Baskent University, Ankara, Turkey, ²Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey
*Purpose: Hypercholesterolemia (HC) induced oxidative stress known to facilitate apoptosis, steatosis, and TGF-β induced liver injury. Apoptosis, in turn, can trigger inflammation, and fibrosis. Apoptotic…
2020 American Transplant Congress
Percutaneous Choledochoscopy and Laser Biliary Stricturoplasty: A Case Series of Novel Management of Refractory Post-Liver Transplant Biliary Complications
W. E. Jackson¹, P. S. Trivedi², J. J. Pomposelli³, T. J. Pshak³
¹Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, ²Division of Vascular and Interventional Radiology, University of Colorado, Aurora, CO, ³Division of Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Anastomotic biliary strictures are a well-recognized complication after living and deceased donor liver transplant (LDLT and DDLT). Management focuses on utilizing endoscopic retrograde cholangiography…
2020 American Transplant Congress
Evaluation of Risk Factors and Outcomes for Hepatic Artery Thrombosis Post Pediatric Liver Transplantation
J. T. McDonald¹, T. Miloh², K. Thompson¹, K. Hosek³, J. Goss¹, C. Kennedy³
¹Baylor College of Medicine, Houston, TX, ²Miami Transplant Institute, Miami, FL, ³Texas Children's Hospital, Houston, TX
*Purpose: Evaluate which transplantation parameters have an association with HAT, as well as to determine the success rate of HAT intervention at TCH since 2011.*Methods:…